Cancer therapy: Less blood means more sanguinity

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Angiostatin, a recently discovered anti-angiogenic factor, offers the hope of long-term control of metastatic cancers following surgery.

Original languageEnglish (US)
Pages (from-to)10-13
Number of pages4
JournalCurrent Biology
Issue number1
StatePublished - Jan 1995

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology
  • General Agricultural and Biological Sciences


Dive into the research topics of 'Cancer therapy: Less blood means more sanguinity'. Together they form a unique fingerprint.

Cite this